+Vote!
Medical News Today (Free subscription) | 06/24/2008
Ankylosing Spondylitis (Bechterew's Disease) is a painful chronic inflammatory rheumatic disease, associated with stiffening of the vertrebral column. Between 100,000 and 150,000 cases have already been diagnosed in Germany, but milder forms of the disease may remain undiagnosed.The research team, led by Dr. Roland R. Wick, with Dr. Elke A. Nekolla, Prof. Dr. Albrecht M. Kellerer and the late Prof....
2Vote!
Medical News Today (Free subscription) | 06/16/2008
EULAR Task Force recommendations suggest inflammation may be the key to heightened cardiovascular risksRheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients should undergo compulsory cardiovascular (CV) risk management and existing CV risk calculators shoul
+Vote!
Eurekalert (Free subscription) | 06/13/2008
( European League Against Rheumatism ) Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients should undergo compulsory cardiovascular risk management and existing CV risk calculators should be adapted to the increased CV risk in inflammatory rheumatic disease patients, the EULAR Task Force on 'Cardiovascular Risk Management in RA' recommended today at EULAR 2008, the Annual...
+Vote!
PharmaGossip (Free subscription) | 05/30/2008
In the UK NICE has recommended two anti-TNF treatments for ankylosing spondylitis, the painful and progressive rheumatic disease, but has excluded a third because of cost effectiveness. Wyeth's Enbrel and Abbott's Humira were recommended by NICE, but it ruled that Schering-Plough's Remicade was too expensive for use on the NHS. Enbrel and Humira can both be injected at home, and cost around £10,000...
+Vote!
Bristol Evening Post (Free subscription) | 04/17/2008
Patients in Bristol with an incurable rheumatic disease are helping a national study.
+Vote!
The Irish Times (Free subscription) | 03/18/2008
Juvenile arthritis is the most common rheumatic disease in children, affecting one in 1,000, explains Dr Orla Killeen, consultant paediatrician at Our Lady's Hospital in Crumlin.
+Vote!
Medical News Today (Free subscription) | 03/07/2008
Physicians at Northwestern Memorial Hospital are studying the effects of an anti-cancer drug to treat patients with scleroderma, a rare, incurable autoimmune rheumatic disease that leads to hardening and tightening of the skin and connective tissues. Scleroderma affects an estimated 300,000 people in the United States and can often attack the lungs, heart, kidneys and intestinal tract, and sometimes...